Athira Pharma Files 8-K on Shareholder Votes

Ticker: LONA · Form: 8-K · Filed: Jun 2, 2025 · CIK: 1620463

Athira Pharma, INC. 8-K Filing Summary
FieldDetail
CompanyAthira Pharma, INC. (LONA)
Form Type8-K
Filed DateJun 2, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

TL;DR

Athira Pharma filed an 8-K for a shareholder vote - details to follow.

AI Summary

Athira Pharma, Inc. filed an 8-K on May 29, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the votes or outcomes, but it fulfills the regulatory requirement for reporting such events.

Why It Matters

This filing indicates that Athira Pharma has held or is holding a shareholder vote, which is a standard corporate governance event. The outcome of these votes could have implications for the company's future direction.

Risk Assessment

Risk Level: low — This filing is a routine corporate governance disclosure and does not contain new financial or operational information that would immediately impact the company's risk profile.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of Athira Pharma's security holders?

The filing states that it is a 'Submission of Matters to a Vote of Security Holders' but does not specify the exact proposals or resolutions presented to the shareholders.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on May 29, 2025.

What is the principal executive office address for Athira Pharma, Inc.?

The principal executive offices are located at 18706 North Creek Parkway, Suite 104, Bothell, WA 98011.

What is the Commission File Number for Athira Pharma, Inc.?

The Commission File Number for Athira Pharma, Inc. is 001-39503.

What is the IRS Employer Identification Number (EIN) for Athira Pharma, Inc.?

The IRS Employer Identification Number for Athira Pharma, Inc. is 45-3368487.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding Athira Pharma, Inc. (LONA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing